Lipid Use in Hospitalized Adults Requiring Parenteral Nutrition

Area of Science:

• Clinical Nutrition
• Immunology
• Inflammation Research

Background:

• Lipid emulsions are essential for parenteral nutrition in hospitalized patients.
• Traditionally, soybean oil was the primary lipid source, mainly for energy and essential fatty acid provision.
• Novel lipid emulsions now incorporate diverse sources like fish oil, rich in omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]).

Purpose of the Study:

• To review clinical and experimental evidence on the use of various lipid emulsions in hospitalized patients.
• To highlight the immunomodulatory and anti-inflammatory effects of omega-3 fatty acids from fish oil.
• To discuss practical considerations for using lipid emulsions in critically ill patients.

Main Methods:

• Review of clinical and experimental studies on lipid emulsion use.
• Examination of evidence for omega-3 fatty acids' effects on inflammation and immune responses.
• Consideration of practical aspects of parenteral nutrition in critical care.

Main Results:

• Omega-3 fatty acids (DHA, EPA) in fish oil exhibit beneficial immunomodulatory, anti-inflammatory, and inflammation-resolution effects.
• These effects are mediated partly by specialized pro-resolution mediators (SPMs).
• Parenteral nutrition with omega-3 fatty acids may reduce infection rates and length of hospital/ICU stay.

Conclusions:

• Mixtures of lipid emulsions, particularly those containing fish oil, offer advantages over traditional soybean oil-based emulsions.
• Omega-3 fatty acids play a crucial role in modulating inflammation and immune responses in various patient groups.
• Optimizing parenteral nutrition with appropriate lipid emulsions can lead to improved clinical outcomes in hospitalized patients.